×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [4]
复旦大学上海医学院 [4]
吉林大学白求恩第一医... [3]
兰州理工大学 [2]
中国医学科学院 北京... [2]
南华大学 [1]
更多...
内容类型
会议论文 [23]
发表日期
2022 [1]
2018 [7]
2017 [2]
2015 [2]
2013 [3]
2012 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共23条,第1-10条
帮助
限定条件
内容类型:会议论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Abnormal gait monitoring system for patients with Parkinson’s disease based on wearable devices
会议论文
Beijing, China, November 5-7, 2022
作者:
Li Yan
;
Bai Qingyuan
;
Yang Xianjun
;
Zhou Xu
;
Sun Yining
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/12/24
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Xu, Nong
;
Shen, Lin
;
Dai, Guanghai
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Shi, Jianhua
;
Feng, Ji Feng
;
Shen, Lin
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Xu, Nong
;
Shen, Lin
;
Dai, Guanghai
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study
会议论文
作者:
Xu, Rui-hua
;
Wang, Fenghua
;
Shi, Jianhua
;
Feng, Ji Feng
;
Shen, Lin
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Biomarker analysis from a phase 1 study of palbociclib (PAL) plus letrozole (L) as first-line treatment for ER+/HER2-advanced breast cancer (ABC) in Chinese women
会议论文
CANCER RESEARCH, 2018-07-01
作者:
Xu, Binghe
;
Zhang, Qingyuan
;
Li, Huiping
;
Sun, Wan
;
Li, Wei
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
Differentially Expressed Trfs in Relapsed & Refractory Diffuse Large B Cell Lymphoma and the Bioinformatic Analysis for Their Potential Clinical Use
会议论文
60th Annual Meeting of the American-Society-of-Hematology (ASH), DEC 01-04, 2018
作者:
Qu, Qingyuan
;
Jiang, Yujie
;
Li, Ying
;
Cai, Yiqing
;
Zhang, Ya
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/31
Smart Transportation Systems for Cities in the Framework of Future Networks
会议论文
4th International Conference on Cloud Computing and Security (ICCCS), JUN 08-10, 2018
作者:
Zhang, Yanwu
;
Li, Lei
;
Li, Guofu
;
Zhu, Pengjia
;
Li, Qingyuan
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/31
Smart transportation system
Wireless networks
Data mining
Palbociclib plus letrozole as first-line treatment for ER-positive and HER2-negative advanced breast cancer in Chinese women: a phase 1 study
会议论文
作者:
Li, Huiping
;
Zhang, Qingyuan
;
Li, Wei
;
Wang, Shusen
;
Liao, Ning
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study
会议论文
作者:
Xu, Ruihua
;
Wang, Fenghua
;
Li, Qi
;
Shi, Jianhua
;
Shen, Lin
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace